Screener
Aura Biosciences, Inc. AURA Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation expense | 274 | 291 |
| Accretion income on marketable securities | (292) | (501) |
| Stock-based compensation expense | 3,824 | 3,514 |
| Other non-cash items | — | 27 |
| Non-cash lease expense | 412 | 374 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other assets | 1,727 | 3,003 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s stock-based comp?
- Aura Biosciences, Inc. (AURA) reported stock-based comp of $3.82M in Q1 2026.
- How has Aura Biosciences, Inc.'s stock-based comp changed year-over-year?
- Aura Biosciences, Inc.'s stock-based comp increased by 8.8% year-over-year, from $3.51M to $3.82M.
- What is the long-term trend for Aura Biosciences, Inc.'s stock-based comp?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s stock-based comp has grown at a 57.8% compound annual growth rate (CAGR), from $2.31M to $14.32M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Aura Biosciences, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude